Trade Mark Journal No.2025/049 5 December 2025

UK00004302491 28 November 2025 (5)

JOIZAFYE

International priority date claimed: 24 July 2025 (Ireland) (202501691)

Class 5: Pharmaceutical preparations for the treatment of viral infection, fungal infection, HIV infection, fibrosis, liver diseases and disorders, hepatitis, hematological diseases and disorders, cancer, inflammatory diseases and disorders, autoimmune diseases and disorders, respiratory and pulmonary diseases and disorders, kidney and nephrotic diseases and disorders, arthritis, obesity, metabolic diseases and disorders and gastrointestinal diseases and disorders; Pharmaceutical preparations for the treatment and prevention of HIV infection.

Gilead Sciences Ireland UC

Representative: Gilead Sciences Europe Ltd